VALEANT PHARMACEUTICALS INTL
VRX
VRX was delisted on the 27th of September, 2010.
1 hedge funds and large institutions have $797K invested in VALEANT PHARMACEUTICALS INTL in 2014 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, reducing their positions, and 1 closing their positions.
25% more capital invested
Capital invested by funds: $639K → $797K (+$158K)
50% less funds holding
Funds holding: 2 → 1 (-1)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CG
Colony Group
Boston,
Massachusetts
|
+$115K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WRM
Westport Resources Management
Westport,
Connecticut
|
-$13K |
VRX Hedge Fund Activity: Q4 2014 in Review
1 of the 3,749 institutional investors tracked by Wall St. Rank reported a position in VALEANT PHARMACEUTICALS INTL (VRX) for Q4 2014, worth a combined $797K — up 25% from $639K a quarter earlier.
Sellers outnumbered buyers: 1 fund closed out of VRX and 0 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 1 added.
The largest buyer was Colony Group, adding an estimated $115K. The largest seller was Westport Resources Management, exiting entirely with an estimated $13K sold.
- 1 institutional investor held VALEANT PHARMACEUTICALS INTL (VRX) as of Q4 2014, down from 2 in Q3 2014.
- Funds reported $797K of VALEANT PHARMACEUTICALS INTL stock for Q4 2014, up 25% quarter-over-quarter.
- 0 funds opened new VALEANT PHARMACEUTICALS INTL positions in Q4 2014 and 1 closed out, a net change of -1 holder.
- The largest VALEANT PHARMACEUTICALS INTL buyer in Q4 2014 was Colony Group, an estimated $115K added.
- The largest VALEANT PHARMACEUTICALS INTL seller in Q4 2014 was Westport Resources Management, an estimated $13K sold.
Based on aggregated 13F filings for Q4 2014.